Блог
Последни новини, научни статии и полезна информация за молекулярната онкологична диагностика и персонализираната терапия.
NIH Grant Disruptions Slow Down Breast Cancer Research
The Trump administration has made the future of federal funding for cancer research uncertain. At one groundbreaking breast cancer research lab, work that could save lives has slowed significantly.
Palbociclib improves progression-free survival in HER2 positive breast cancer
PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the New England Journal of Medicine (NEJM).
Gyles Brandreth on grandson’s cancer diagnosis: ‘A shock to the system’
‘We think of cancer as something that happens to unlucky middle-aged people,’ says the TV personality
International Cancer Organizations Work Together to Meet the Needs of Women with Cancer in Vietnam
International Cancer Organizations Work Together to Meet the Needs of Women with Cancer in Vietnam
GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-5550 TriKE®, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors Expressing B7-H3
GTB-5550 Phase 1 dose escalation basket trial expected to initiate mid-2026 Phase 1 protocol allows multiple solid tumor types known to express B7-H3 ...
Breast Cancer Treatment: Experts say it’s time to focus on quality of life in early-stage breast cancer treatment
Living with early breast cancer involves more than just treatment; it's about maintaining quality of life and personal identity. Women are navigating
Страница 9 от 13 • Общо 75 статии